Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-21

Clinical Trial Update: Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating carboxyamidotriazole for advanced kidney cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carboxyamidotriazole (carboxyamidotriazole)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED